Biotechnology
ViRexx Medical Corp. , a company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for living. Its platform technologies include product candidates for the treatment of Hepatitis B, Hepati
5 hours ago
ViRexx Medical Corp. , a company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for living. Its platform technologies include product candidates for the treatment of Hepatitis B, Hepati
5 hours ago
Medicure Inc. , a cardiovascular focused, biopharmaceutical company, today reported the results of operations for the fiscal year ended May 31, 2008. All amounts referenced herein are in Canadian dollars unless otherwise noted.
7 hours ago
"Cylex, Inc., in association with our Korean distributor, Sun Woo Biotech, is delighted to be able to announce our support for a major, multi-center trial of the ImmuKnow assay for cell-mediated immunity at seven highly respected medical institution
7 hours ago
CardioComm Solutions, Inc. today announced that it has closed its previously announced non-brokered private placement equity financing. Under the financing, the Company issued 6,666,666 units at a price of $0.075 per unit, with each unit comprising one c
8 hours ago
Allon Therapeutics Inc. announced today that in a Phase IIa clinical trial evaluating the potential of its drug AL-208 to prevent or reduce mild cognitive impairment in patients who undergo coronary artery bypass graft surgery the single-dose had no obse
8 hours ago
Truman Medical Centers became one of the first hospitals inthe United States to install the Siemens SOMATOM Definition AS 128 slice CT scanner this week. The 128-slice CT scanner is a highly adaptive scanner, providing exceptional image quality with mini
8 hours ago
Orexigen Therapeutics, Inc. , a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, today announced that the Company will be presenting at the following upcoming investor conferences:
8 hours ago
|